These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 6820589)
1. [Antibacterial effect of N-formimidoyl-thienamycin in combination with amikacin, cefoxitin and fosfomycin on K. pneumoniae and P. aeruginosa]. Schröter G; Schrettenbrunner A Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Dec; 253(3):355-7. PubMed ID: 6820589 [No Abstract] [Full Text] [Related]
2. In vitro activity of newer beta-lactam agents in combination with amikacin against Pseudomonas aeruginosa, Klebsiella pneumoniae, and Serratia marcescens. Meyer RD; Pasiecznik K Diagn Microbiol Infect Dis; 1983 Dec; 1(4):287-93. PubMed ID: 6321092 [TBL] [Abstract][Full Text] [Related]
3. N-formimidoyl-thienamycin and norfloxacin against multiple-resistant Pseudomonas aeruginosa strains. Combined in vitro activity and comparison with 14 other antibiotics. Martino P; Venditti M; Valente B; Brandimarte C; Serra P Drugs Exp Clin Res; 1985; 11(4):247-51. PubMed ID: 3939121 [TBL] [Abstract][Full Text] [Related]
4. In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa. Tessier F; Quentin C Eur J Clin Microbiol Infect Dis; 1997 Feb; 16(2):159-62. PubMed ID: 9105845 [TBL] [Abstract][Full Text] [Related]
5. [Effect of superinhibitory levels of imipenem and amikacin singly or in combination on Pseudomonas aeruginosa]. Hostacká A Epidemiol Mikrobiol Imunol; 1997 Dec; 46(4):155-7. PubMed ID: 9471306 [TBL] [Abstract][Full Text] [Related]
6. [Effect of multiresistance on the minimal inhibitory concentration of N-formimidoyl thienamycin and 6 comparing substances against P. aeruginosa and 4 Enterobacteriaceae species]. Schröter G; Schrettenbrunner A; Strenzel I Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Feb; 253(4):531-43. PubMed ID: 6407236 [TBL] [Abstract][Full Text] [Related]
7. In vitro evaluation of N-formimidoyl thienamycin (MK0787) combined with amikacin against gram-negative bacilli and Staphylococcus aureus. Díez Enciso M; Mateos Lindemann M; Gutiérrez Altés A Antimicrob Agents Chemother; 1982 Dec; 22(6):1064-6. PubMed ID: 6818899 [TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamics of Aerosolized Fosfomycin and Amikacin against Resistant Clinical Isolates of Pseudomonas aeruginosa and Klebsiella pneumoniae in a Hollow-Fiber Infection Model: Experimental Basis for Combination Therapy. Sime FB; Johnson A; Whalley S; Santoyo-Castelazo A; Montgomery AB; Walters KA; Lipman J; Hope WW; Roberts JA Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795380 [TBL] [Abstract][Full Text] [Related]
9. The effect of amikacin and imipenem alone and in combination against an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain. Máthé A; Szabó D; Anderlik P; Rozgonyi F; Nagy K Diagn Microbiol Infect Dis; 2007 May; 58(1):105-10. PubMed ID: 17300908 [TBL] [Abstract][Full Text] [Related]
10. [Bactericidal kinetics of cefazolin, cefoxitin and amikacin alone and in combination (author's transl)]. Shah PM; Stille W Arzneimittelforschung; 1978; 28(9):1539-41. PubMed ID: 383106 [TBL] [Abstract][Full Text] [Related]
11. In vitro activity of fosfomycin combined with rifampin, pefloxacin and imipenem against staphylococci: a study by the time-kill curve method. Quentin C; Saivin S; Lafferriere C; Noury P; Bebear C Drugs Exp Clin Res; 1987; 13(4):219-24. PubMed ID: 3476291 [TBL] [Abstract][Full Text] [Related]
12. In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa. Pruekprasert P; Tunyapanit W Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1239-42. PubMed ID: 16438151 [TBL] [Abstract][Full Text] [Related]
13. Synergism of imipenem and amikacin in combination with other antibiotics against Nocardia asteroides. Gombert ME; Aulicino TM Antimicrob Agents Chemother; 1983 Nov; 24(5):810-1. PubMed ID: 6362558 [TBL] [Abstract][Full Text] [Related]
14. Postantibiotic effect of imipenem, alone and in combination with amikacin, on Pseudomonas aeruginosa. Gerçeker AA; Otük G Chemotherapy; 1995; 41(6):433-6. PubMed ID: 8529433 [TBL] [Abstract][Full Text] [Related]
15. Synergistic effect of N-formimidoyl thienamycin with gentamicin and amikacin against Streptococcus faecalis. Gombert ME; Berkowitz LB; Cummings MC Antimicrob Agents Chemother; 1983 Feb; 23(2):245-7. PubMed ID: 6404218 [TBL] [Abstract][Full Text] [Related]
16. In vitro investigations on the action fosfomycin alone and in combination with other antibiotics on Pseudomonas aeruginosa and Serratia marcescens. Ullmann U; Lindemann B Arzneimittelforschung; 1980; 30(8):1247-9. PubMed ID: 6776966 [TBL] [Abstract][Full Text] [Related]
17. [Effects of beta-lactamases on the antibacterial activity of carumonam and aztreonam against Klebsiella sp. in comparison with 4 other beta-lactams]. Labia R; Morand A; Pitton JS; Philippin JL; Fournier P Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):796-9. PubMed ID: 3309817 [TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility of cephalothin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to Amikacin and selected new beta-lactam agents. McNamara BT; Meyer RD; Pasiecznik KA Antimicrob Agents Chemother; 1982 May; 21(5):753-7. PubMed ID: 6213196 [TBL] [Abstract][Full Text] [Related]
19. The morphological response of Pseudomonas aeruginosa to azthreonam, cefoperazone, ceftazidime and N-formimidoyl thienamycin. Elliott TS; Greenwood D J Med Microbiol; 1984 Apr; 17(2):159-69. PubMed ID: 6423826 [TBL] [Abstract][Full Text] [Related]